IFNG and neoplasm: Besides its ability to trigger cell cycle arrest and apoptosis [7–10], IFN-γ shows anti-tumor activity in patients with advanced head and neck squamous cell carcinoma (HNSCC) [11] or non-small-cell lung carcinoma (NSCLC) [12].